National Cancer Institute; Notice of Closed Meeting, 60740-60741 [06-8705]
Download as PDF
<![CDATA[
60740
Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
October 26, 2006, 11 a.m. to October 26,
2006, 3 p.m. NIH Events Management,
Executive Plaza, North, 6130 Executive
Boulevard, Conference Room C,
Rockville, MD 20852 which was
published in the Federal Register on
September 22, 2006, 71 FR 55498.
The meeting notice is changed to
reflect the name of the committee from
‘‘SBIR Topics 210 and 213’’ to ‘‘SBIR
Topic 210 Phase II ‘Using Social
Marketing to Disseminate Evidencebased Energy Balance Intervention
Approaches to Worksites’ ’’ The meeting
is closed to the public.
Dated: October 6, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8693 Filed 10–13–06; 8:45 am]
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd. 7149,
Bethesda, MD 20892. 301/594–1286.
peguesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 6, 2006.
Linda Payne
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8695 Filed 10–13–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–M
National Cancer Institute; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, SBIR Topic
204 (Phase II), ‘‘Plant Genomic Models for
Establishing Physiological Relevance of
Bioactive Components as Cancer
Protectants’’.
Date: November 8, 2006.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
VerDate Aug<31>2005
16:16 Oct 13, 2006
Jkt 211001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, ‘‘In Vivo
Cellular and Molecular Imaging Centers
(ICMICS)’’.
Date: November 14–15, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Kenneth L Bielat, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
7147, Bethesda, MD 20892. (301) 496–7576.
bielatk@mail.nih.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Special Emphasis Panel, CA–06–
505, Cancer Research Network.
Date: November 20, 2006.
Time: 8 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Gerald G. Lovinger, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8101,
Bethesda, MD 20892–8329. 301/496–7987.
lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Development of Advanced Genomic
Characterization Technologies.
Date: November 29–30, 2006.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Thomas M. Vollberg, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 7142,
Bethesda, MD 20892. 301/594–9582.
vollbert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: October 6, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8696 Filed 10–13–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, RFA
CA07–025 Community Clinical Oncology
Program & RFA CA07–026 Minority-Based
Community Clinical Oncology Program.
Date: December 5–7, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Administrator, Special
Review and Resources Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Room 8105, Bethesda,
MD 20892–7405; (301) 496–7575.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 10, 2006.
Linda A. Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8705 Filed 10–13–06; 8:45 am]
Special Emphasis Panel, Training and
Education.
Date: November 6–7, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluation grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Administrator, Office
of Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Dietary Supplement
Research Centers.
Date: November 16, 2006.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluation grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hills
Road, Bethesda, MD 20814.
Contact Person: Martina Schmidt, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–594–3456,
schmidma@mail.nih.gov.
Dated: October 5, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8702 Filed 10–13–06; 8:45 am]
60741
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, Washington,
DC 20015.
Contact Person: Houmam H. Araj, PhD,
Scientific Review Administrator, Division of
Extramural Research, National Eye Institute,
NIH, 5635 Fishers Lane, Suite 1300,
Bethesda, MD 20892–9602, 301–451–2020,
haraj@mail.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Core and
Conference Grant Applications.
Date: November 30, 2006.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Anne E. Schaffner, PhD,
Scientific Review Administrator, Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300;
Bethesda, MD 20892–9300, (301) 451–2020;
aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: October 5, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8700 Filed 10–13–06; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Eye Institute; Notice of Closed
Meetings
jlentini on PROD1PC65 with NOTICES
National Center for Complementary
and Alternatives Medicine; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
VerDate Aug<31>2005
16:16 Oct 13, 2006
Jkt 211001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Clinical and Epi
Grant Applications.
Date: November 20, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel Fellowship.
Date: December 5, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Pooks Hill, 5151
Pooks Hill Road, Bethesda, MD 20814.
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 71, Number 199 (Monday, October 16, 2006)]
[Notices]
[Pages 60740-60741]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8705]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 60741]]
and personal information concerning individuals associated with the
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, RFA CA07-025 Community Clinical Oncology Program & RFA CA07-
026 Minority-Based Community Clinical Oncology Program.
Date: December 5-7, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD
20877.
Contact Person: Lalita D. Palekar, PhD, Scientific Review
Administrator, Special Review and Resources Branch, Division of
Extramural Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda,
MD 20892-7405; (301) 496-7575.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: October 10, 2006.
Linda A. Payne,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8705 Filed 10-13-06; 8:45 am]
BILLING CODE 4140-01-M
